share_log

Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SHERMAN JEFFREY W

SEC announcement ·  Nov 29, 2023 16:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more